Match tier Confirmed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-09

Z. Ryan Tian

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Federal Grant PI High Impact

Professor

Also affiliated: Hebei Medical University (2021); Jiangsu University (2019–2020); Uppsala University (2007–2012); Uppsala University Hospital (2012); University of Connecticut (1996–1999); Emory University (2020); Xinjiang Medical University (2013–2023); Shenyang University of Technology (2025); Chiba University (2018–2021); Tianjin University (2011); University of St Andrews (2017); University of New Mexico (2006–2007); Lehigh University (2014–2019); Jilin University (2006); Chinese Academy of Medical Sciences & Peking Union Medical College (2020–2022); Changchun Normal University (2025); Missouri University of Science and Technology (2013); Hubei University of Chinese Medicine (2025); Beijing Jiaotong University (2026); University of Arkansas System (2023); China-Japan Friendship Hospital (2020–2022); First Affiliated Hospital of Xinjiang Medical University (2013–2023); University of California San Diego (2020); Third Hospital of Hebei Medical University (2021); Chinese Academy of Inspection and Quarantine (2019–2021); Sandia National Laboratories (2006); Ningxia Medical University (2025); Ningxia Medical University General Hospital (2025); Institute of Hematology & Blood Diseases Hospital (2020); Center for Forensic Mental Health, Chiba University (2018–2021); Winship Cancer Institute (2020); State Key Laboratory of Optoelectronic Materials and Technology (2006); State Key Laboratory of Inorganic Synthesis and Preparative Chemistry (2006); Institute of Spacecraft System Engineering (2023); East China Normal University (2022–2024); Tsinghua University (2006–2007)

31 h-index 225 pubs 4,206 cited

  • Neuroprotective Agents
  • Humans
  • Animals
  • Nanowires
  • Male
  • Rats
  • Brain
  • Amino Acids
  • Drug Delivery Systems
  • Spinal Cord Injuries
  • Alzheimer Disease
  • Parkinson Disease
  • Mesenchymal Stem Cells
  • Titanium
  • Brain Injuries, Traumatic

Biography and Research Information

OverviewAI-generated summary

Z. Ryan Tian's research interests include the development and application of nanomaterials for various biomedical purposes. His work has explored the synthesis of complex nanostructures, such as branched ZnO crystallites and multifunctional nanowire bioscaffolds on titanium. A significant portion of his research has focused on the neuroprotective potential of nanomaterials, including studies on how chronic nanoparticle treatment can exacerbate hyperthermia-induced blood-brain barrier breakdown and cognitive dysfunction in rats, and the potential of nanowired-antioxidant compounds to mitigate these effects.

Dr. Tian has also investigated porous manganese oxide materials and their electrical resistivity properties. In addition to his work in nanomaterials and neuroscience, he has explored other areas, including a review of porous manganese oxide materials and a model for tooth wear with implications for microwear formation and diet reconstruction. He is also a principal investigator on an NSF I-Corps grant focused on the commercialization of a real-time, palm-size, low-cost, and wireless SARS-COV-II detector.

With an h-index of 31, over 250 publications, and more than 4,300 citations, Dr. Tian has a substantial publication record. His collaborations include research with Mark Lanoue, Asya Ozkızılcık, Parker Cole, and Savannah Thornburgh, all from the University of Arkansas at Fayetteville.

Metrics

  • h-index: 31
  • Publications: 225
  • Citations: 4,206

Positions

  • Professor 2023–present
    University of Arkansas Department of Chemistry and Biochemistry ORCID
  • Associate Professor/ Assistant Professor 2004–2016
    University of Arkansas Fayetteville Chemistry and Biochemistry ORCID
  • Post Doctoral Fellow 2002–2004
    Sandia National Laboratories Nanomaterial and Interfacial Science ORCID
  • Manager 2000–2001
    AXT Inc. R&D/Production/Tech-Transfer ORCID
  • Post Doc. Researcher 1998–2000
    University of California Davis Chemical Engineering and Materials Science ORCID

Selected Publications

  • Retraction Note: Cerebrolysin Attenuates Exacerbation of Neuropathic Pain, Blood-Spinal Cord Barrier Breakdown and Cord Pathology Following Chronic Intoxication of Engineered Ag, Cu or Al (50–60 nm) Nanoparticles (2026)
  • Retraction Note to: Timed Release of Cerebrolysin Using Drug-Loaded Titanate Nanospheres Reduces Brain Pathology and Improves Behavioral Functions in Parkinson’s Disease (2026)
  • Retraction Note to: Nanowired Delivery of Growth Hormone Attenuates Pathophysiology of Spinal Cord Injury and Enhances Insulin-Like Growth Factor-1 Concentration in the Plasma and the Spinal Cord (2026)
  • Surface properties and in-vitro bioactivity studies of TiO2 nanowire doped transition metal (M=Fe, Co, and Mn) (2026)
  • Novel Nanomaterials for Developing Bone Scaffolds and Tissue Regeneration (2025)
    Nanomaterials 26 citations DOI OpenAlex
  • Hydrothermally doping valve metal Nb into Titanate nanofibers structure for potentially engineering bone tissue (2024)
    Nano and Medical Materials 1 citation DOI OpenAlex
  • Efficient Photocatalytic Core–Shell Synthesis of Titanate Nanowire/rGO (2024)
    Catalysts 7 citations DOI OpenAlex
  • Mo-doped titanate nanofibers from hydrothermal syntheses for improving bone scaffold (2024)
    Characterization and Application of Nanomaterials 7 citations DOI OpenAlex
  • Hydrothermal synthesis of valve metal Ta-doped titanate nanofibers for potentially engineering bone tissue (2024)
    Characterization and Application of Nanomaterials 5 citations DOI OpenAlex
  • Hydrothermal synthesis of valve metal Zr-doped titanate nanofibers for bone tissue engineering (2023)
    Nano and Medical Materials 6 citations DOI OpenAlex
  • Spinal cord injury induced exacerbation of Alzheimer's disease like pathophysiology is reduced by topical application of nanowired cerebrolysin with monoclonal antibodies to amyloid beta peptide, p-tau and tumor necrosis factor alpha (2023)
    International review of neurobiology 1 citation DOI OpenAlex
  • Co-administration of dl-3-n-butylphthalide and neprilysin is neuroprotective in Alzheimer disease associated with mild traumatic brain injury (2023)
    International review of neurobiology 2 citations DOI OpenAlex
  • Nicotine neurotoxicity exacerbation following engineered Ag and Cu (50–60 nm) nanoparticles intoxication. Neuroprotection with nanowired delivery of antioxidant compound H-290/51 together with serotonin 5-HT3 receptor antagonist ondansetron (2023)
    International review of neurobiology 5 citations DOI OpenAlex
  • Sleep deprivation enhances amyloid beta peptide, p-tau and serotonin in the brain: Neuroprotective effects of nanowired delivery of cerebrolysin with monoclonal antibodies to amyloid beta peptide, p-tau and serotonin (2023)
    International review of neurobiology 2 citations DOI OpenAlex
  • Nanowired delivery of antibodies to tau and neuronal nitric oxide synthase together with cerebrolysin attenuates traumatic brain injury induced exacerbation of brain pathology in Parkinson’s disease (2023)
    International review of neurobiology 2 citations DOI OpenAlex

View all publications on OpenAlex →

Federal Grants 1 $50,000 total

Collaboration Network

214 Collaborators 53 Institutions 13 Countries

Top Collaborators

Similar Researchers

Based on overlapping research topics